Practice Management News

Hepatitis C virus reinfection was common in five Australian prisons, a study found — especially among injection drug users, highlighting the need for post-treatment surveillance and increased services, researchers said.

Measuring hepatitis C virus at baseline and on days 7 and 14 of therapy — and eliminating blood draws on days 2 and 28 — can identify patients who may be eligible for a shorter duration of therapy, according to a study.

The COVID-19 pandemic reduced the world’s life expectancy by about 2 years, according to recent estimates published in Population and Development Review.

On one hand, the tax tactic described in this article applies only to a limited number of physicians: those who are in private practice and in practices that are taxed as S corporations.

A team of researchers assembled the first complete sequence of a human genome, 2 decades after the Human Genome Project formed the first incomplete draft sequence, according to the NIH.

Direct-acting antivirals for hepatitis C have dominated hepatitis research for the past decade and have revolutionized the treatment of HCV, but the emergence of new treatment options has put hepatitis D back in the spotlight.

Autoimmune treatments accounted for more than half of all specialty drug growth in 2021, according to a drug trend report released by CVS Health.

Almost 16 million Americans who enrolled in Medicaid during the public health emergency could lose coverage when the emergency declaration ends if it expires after the third quarter of 2022.

The passage of the Build Back Better Act by the Senate has been put on the back burner. But it makes sense for high-income earners and those with large retirement account balances to understand the provisions in the version of the bill passed by the U.S. House of Representatives in November 2021.

The COVID-19 pandemic disrupted progress toward gender equity in medicine that may resonate for years to come, according to experts.